ARF6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane Microvesicles

[1]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[2]  James W. Clancy,et al.  ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo. , 2009, Cancer research.

[3]  U. Rapp,et al.  A-RAF Kinase Functions in ARF6 Regulated Endocytic Membrane Traffic , 2009, PloS one.

[4]  Jacopo Meldolesi,et al.  Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.

[5]  C. D’Souza-Schorey,et al.  ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway. , 2009, Cancer research.

[6]  Yoshihiko Ito,et al.  The relaxant effect of okadaic acid on canine basilar artery involves activation of PKCalpha and phosphorylation of the myosin light chain at Thr-9. , 2008, European journal of pharmacology.

[7]  Pierre Nassoy,et al.  MT1-MMP-Dependent Invasion Is Regulated by TI-VAMP/VAMP7 , 2008, Current Biology.

[8]  A. Ridley,et al.  Rho GTPases in cancer cell biology , 2008, FEBS letters.

[9]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[10]  T. Manabe,et al.  GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion , 2008, Nature Cell Biology.

[11]  C. D’Souza-Schorey,et al.  ARF6‐dependent activation of ERK and Rac1 modulates epithelial tubule development , 2007, The EMBO journal.

[12]  G. Parmiani,et al.  Tumor-released microvesicles as vehicles of immunosuppression. , 2007, Cancer research.

[13]  María C Montoya,et al.  MT1‐MMP proinvasive activity is regulated by a novel Rab8‐dependent exocytic pathway , 2007, The EMBO journal.

[14]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[15]  Crislyn D'Souza-Schorey,et al.  ARF proteins: roles in membrane traffic and beyond , 2006, Nature Reviews Molecular Cell Biology.

[16]  Rebecca Slack,et al.  Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. , 2006, Experimental cell research.

[17]  J Ratajczak,et al.  Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery , 2006, Leukemia.

[18]  G. Taraboletti,et al.  Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. , 2006, Neoplasia.

[19]  Robert E. Lewis,et al.  Extracellular signal-regulated kinase regulates clathrin-independent endosomal trafficking. , 2005, Molecular biology of the cell.

[20]  J. Donaldson,et al.  An effector domain mutant of Arf6 implicates phospholipase D in endosomal membrane recycling. , 2005, Molecular biology of the cell.

[21]  K. Linton,et al.  Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes , 2005, Nature Cell Biology.

[22]  J. Freyssinet,et al.  Membrane microparticles: two sides of the coin. , 2005, Physiology.

[23]  C. D’Souza-Schorey,et al.  Investigating the role of ADP-ribosylation factor 6 in tumor cell invasion and extracellular signal-regulated kinase activation. , 2005, Methods in enzymology.

[24]  D. Fishman,et al.  Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles , 2004, Cancer Research.

[25]  G. Raposo,et al.  Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.

[26]  C. D’Souza-Schorey,et al.  ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Freyssinet,et al.  Cellular microparticles: a disseminated storage pool of bioactive vascular effectors , 2004, Current opinion in hematology.

[28]  Y. Onodera,et al.  Requirement for Arf6 in breast cancer invasive activities. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Canevari,et al.  Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro , 1999, Clinical & Experimental Metastasis.

[30]  J. Donaldson.  Multiple Roles for Arf6: Sorting, Structuring, and Signaling at the Plasma Membrane* , 2003, Journal of Biological Chemistry.

[31]  M. Crow,et al.  Phorbol esters increase MLC phosphorylation and actin remodeling in bovine lung endothelium without increased contraction. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[32]  J. Freyssinet.  Cellular microparticles: what are they bad or good for? , 2003, Journal of thrombosis and haemostasis : JTH.

[33]  M. Rizzo,et al.  The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade , 2002, FEBS letters.

[34]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[35]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[36]  Vincenza Dolo,et al.  Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. , 2002, The American journal of pathology.

[37]  P. Vincent,et al.  p38 MAPK activation by TGF-beta1 increases MLC phosphorylation and endothelial monolayer permeability. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[38]  C. Reutelingsperger,et al.  Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. , 2001, Journal of cell science.

[39]  R. Seger,et al.  Altered Regulation of ERK1b by MEK1 and PTP-SL and Modified Elk1 Phosphorylation by ERK1b Are Caused by Abrogation of the Regulatory C-terminal Sequence of ERKs* , 2001, The Journal of Biological Chemistry.

[40]  J. Hong,et al.  Enhancement of lysophosphatidic acid-induced ERK phosphorylation by phospholipase D1 via the formation of phosphatidic acid. , 2001, Biochemical and biophysical research communications.

[41]  S. L. Gonias,et al.  Myosin Light Chain Kinase Functions Downstream of Ras/ERK to Promote Migration of Urokinase-Type Plasminogen Activator-Stimulated Cells in an Integrin-Selective Manner , 1999, The Journal of cell biology.

[42]  S. Canevari,et al.  Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. , 1998, Cancer research.

[43]  David A. Cheresh,et al.  Regulation of Cell Motility by Mitogen-activated Protein Kinase , 1997, The Journal of cell biology.

[44]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[45]  V. Lefebvre,et al.  An assay for matrix metalloproteinases and other proteases acting on proteoglycans, casein, or gelatin. , 1993, Analytical biochemistry.

[46]  A. Sobieszek,et al.  Ca(2+)-calmodulin-dependent modification of smooth-muscle myosin light-chain kinase leading to its co-operative activation by calmodulin. , 1993, The Biochemical journal.